Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex

By: via Benzinga
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") today announced that the European Medicines Agency ("EMA") has determined ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.